EU publishes notification of Novartis’s plan to buy Glaxo cancer drugs portfolio
MLex Summary: The European Commission today published in the Official Journal the notification of plans by Novartis to acquire GlaxoSmithKline’s portfolio of cancer drugs.The full notification follows....To view the full article, register now.
Already a subscriber? Click here to view full article